Belite Bio, Inc. (BLTE) at a glance

Belite Bio, Inc. (BLTE) is a mid-cap Healthcare company. It trades at $173.79, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 58/100 overall. Its strongest dimension is Safety (86/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$173.79

Market cap

$5.54B

P/E ratio

n/a

Dividend yield

None

Beta

-1.24

52-week range

$62.18 to $200.00